Suppliers / Rini Life Science

Rini Life Science

India Updated 9 July 2026

Rini Life Science is an API manufacturer based in India. It holds one active US drug master file. Customs aggregates show $1.1M of exports covering 89 molecules to 20 destinations in 2025.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Chlorzoxazone US FDA 1

Also appears on these molecule pages

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $88K 3
2025 Not reported $1.1M 20
2024 Not reported $1.1M 14
2023 Not reported $1.2M 13

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Rini Life Science

Does Rini Life Science hold a US DMF or a CEP?
Rini Life Science holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Rini Life Science make?
1 molecule is on record against Rini Life Science, including Chlorzoxazone. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Rini Life Science comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts